A detailed history of Point72 (Difc) LTD transactions in Axogen, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 132 shares of AXGN stock, worth $1,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132
Previous 2,283 94.22%
Holding current value
$1,760
Previous $16.5 Million 88.8%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $14.69 $16,175 - $31,598
-2,151 Reduced 94.22%
132 $1.85 Million
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $351 - $499
62 Added 2.79%
2,283 $16.5 Million
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $14,725 - $23,742
2,221 New
2,221 $17.9 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $564M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.